GlassScriptPhysician profile
Nikki M Miracle
NPI 1205050754
$2,774.68
in general payments reported to CMS, 2019-2025
24 companies · $81.49 in 2025
The $81.49 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $286 · 2021: $657 · 2022: $508 · 2023: $339 · 2024: $278 · 2025: $81.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $441.51 | 2020-2024 | Affinity, Puraply |
| Horizon Therapeutics Plc | $390.72 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $276.72 | 2019-2022 | |
| Kerecis Limited | $264.61 | 2020-2022 | |
| Abbott Laboratories | $211.01 | 2019-2021 | |
| Axogen | $165.93 | 2021 | |
| Paratek Pharmaceuticals, INC. | $153.11 | 2022-2025 | Nuzyra |
| Cumberland Pharmaceuticals, INC. | $152.85 | 2024 | Vibativ |
| Nevro Corp. | $139.20 | 2021-2022 | |
| Triad Life Sciences INC. | $99.95 | 2022 | |
| Lifenet Health | $81.71 | 2023 | |
| Stryker Corporation | $70.26 | 2019-2020 | |
| Solventum Corporation | $66.13 | 2025 | Activ.A.C., V.A.C.Instill, Prevena |
| Misonix INC | $60.79 | 2019 | |
| Tactile Systems Technology INC | $31.62 | 2024 | Entre Plus, Flexitouch Plus |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $29.43 | 2019 | |
| Zimvie INC. | $26.46 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.44 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $20.00 | 2019 | |
| Nabriva Therapeutics, Plc | $16.00 | 2021 | |
| Paragon 28, INC. | $15.92 | 2024 | Gorilla |
| Amgen INC. | $14.15 | 2024 | Krystexxa |
| Advanced Oxygen Therapy INC. | $13.46 | 2024 | Topical Oxygen Chamber For Extremities |
| Arthrosurface Incorporated | $10.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikki Miracle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.